Table 3.
Patient factors | Clinician factors | System factors | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of medicationsa | Increasing ageb | Female sexc | Race and ethnicityd | Level of education | Marital status | No. outpatient/ED visits | No. of hospital admissions | No. of prescribers | More medical comorbidity | Presence of psychiatric comorbidity | Worse functional status | Cognitive impairment | Clinician age, sex, years of experience | Time spent | Proportion of patients >75 years | Specialtye | Geographic region (south) | Rural site of care | Insurance typef | |
Administrative data | ||||||||||||||||||||
Zhang (2010)[27]g | ||||||||||||||||||||
Woelfel (2011)[20] | + | 0 | 0 | |||||||||||||||||
Blackwell (2012)[29] | + | − | + | + | + | + | + | |||||||||||||
Holmes (2013)[31] | + | 0 | + | + | + | + | 0 | |||||||||||||
Lund (2013)[32] | + | + | ||||||||||||||||||
Jiron (2016)[35] | + | − | + | + | 0 | 0 | + | + | + | + | ||||||||||
Kester, 2016)[36] | + | + | 0 | + | + | + | ||||||||||||||
Chart review | ||||||||||||||||||||
Buck (2008)[25] | + | + | + | 0 | + | |||||||||||||||
Hu (2012)[28] | + | − | 0 | 0 | ||||||||||||||||
Prithviraj (2012)[30] | + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||
Nightingale (2015)[39] | + | 0 | 0 | 0 | + | 0 | ||||||||||||||
DiNapoli (2016)[34] | 0 | 0 | 0 | + | ||||||||||||||||
Ie (2017)[40] | + | |||||||||||||||||||
Nationally representative survey | ||||||||||||||||||||
Zhang (2011)[21] | + | 0 | + | 0 | 0 | + | 0 | 0 | ||||||||||||
Kachru (2015)[22] | − | + | 0 | − | 0 | + | 0 | + | 0 | |||||||||||
Extavour (2016)[24] | + | + | 0 | + | − | 0 | 0 | 0 | ||||||||||||
Miller (2016)[23] | + | − | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||
Swanoski (2017)[37] | − | + | + | + | + | |||||||||||||||
Other | ||||||||||||||||||||
Weston (2010)[26] | + | 0 | + | 0 | + | 0 | 0 | |||||||||||||
Koyama (2013)[33] | + | |||||||||||||||||||
Mattos (2016)[38] | + | 0 | 0 | 0 | 0 | 0 | + | + | ||||||||||||
Shade (2017)[41] | + | 0 | 0 | 0 | 0 |
No., number; +, positive association with risk of PIM use; −, negative association with risk of PIM use; 0, no statistically significant association with risk of PIM use.
Number of medications examined as a continuous and categorical variable across studies.
Age was examined as a continuous and categorical variable with categories ranging from 5 to 20 years.
Male sex was examined in all 16 studies and was significant in 0 studies.
Results were conflicted with varying reference groups.
Specialties examined varied.
Results were conflicting with studies comparing varying payer types. Two studies, which looked specifically at Medicare–Medicaid dual eligibility, found a significant positive association.
This study did not examine any of the listed characteristics, it examined adjusted gross spending, see Table 1.